Article ID Journal Published Year Pages File Type
7280423 Brain, Behavior, and Immunity 2016 38 Pages PDF
Abstract
Together, these results suggest that TAK-242 is a TLR4 antagonist that has efficacy after systemic and intrathecal delivery and confirms the role of endogenous TLR4 signaling in triggering the development of a delayed allodynia in both male and female mice.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , , , , , ,